AstraZeneca (AZN)
(Real Time Quote from BATS)
$79.18 USD
+2.07 (2.68%)
Updated May 21, 2024 03:39 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Brokerage Reports
0 items in cart
AstraZeneca PLC [AZN]
Reports for Purchase
Showing records 181 - 200 ( 256 total )
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan 20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Sector Analysis Update: Molecular Diagnostics: Does the Turnaround have ''''Legs''''?
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended July 22
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended June 17
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 6
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D